Selected article for: "histocompatibility complex and major MHC class histocompatibility complex"

Author: Stäger, Simona; Rafati, Sima
Title: CD8(+) T Cells in Leishmania Infections: Friends or Foes?
  • Document date: 2012_1_24
  • ID: uofygmeu_3
    Snippet: CD8 + T cells recognize peptides that are presented in the context of major histocompatibility complex (MHC) class I molecules via the T cell receptor (TCR). Although peptides presented via MHCI mainly derive from endogenous antigens, various exogenous cellassociated antigens have also been shown to be uploaded onto the MHCI pathway, by a process referred to as cross-presentation. Leishmania antigens were also shown to be cross-presented (Berthol.....
    Document: CD8 + T cells recognize peptides that are presented in the context of major histocompatibility complex (MHC) class I molecules via the T cell receptor (TCR). Although peptides presented via MHCI mainly derive from endogenous antigens, various exogenous cellassociated antigens have also been shown to be uploaded onto the MHCI pathway, by a process referred to as cross-presentation. Leishmania antigens were also shown to be cross-presented (Bertholet et al., 2006) . During in vivo infections, cross-presentation of Leishmania antigens may result from several internalization pathways, such as direct infection, receptor-mediated uptake (Woelbing et al., 2006) , or internalization of apoptotic vesicles (Winau et al., 2006) . Thus far, two different processing pathways have been proposed. An early work demonstrated that a surface antigen of L. amazonensis was processed in a proteasome-dependent manner within the cytosol (Kima et al., 1997) . In contrast, a more recent study showed that cross-presentation of secreted leishmanial antigens is confined to an intraphagosomal processing pathway that is TAP-and proteasome-independent (Bertholet et al., 2006) .

    Search related documents:
    Co phrase search for related documents
    • major MHC class histocompatibility complex and MHC class histocompatibility complex: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
    • major MHC class histocompatibility complex context and MHC class: 1, 2
    • major MHC class histocompatibility complex context and MHC class histocompatibility complex: 1, 2
    • MHC class and processing pathway: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • MHC class and recent study: 1, 2, 3
    • MHC class and surface antigen: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • MHC class and vivo infection: 1, 2, 3, 4, 5, 6, 7
    • MHC class histocompatibility complex and recent study: 1
    • MHC class histocompatibility complex and surface antigen: 1, 2, 3
    • MHC class histocompatibility complex and vivo infection: 1, 2, 3
    • recent study and surface antigen: 1
    • recent study and vivo infection: 1, 2, 3, 4, 5, 6, 7
    • receptor mediate and vivo infection: 1
    • surface antigen and vivo infection: 1